Is Caffeine an Environmental Modifier in Huntington's Disease?

NCT03034122 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 77

Last updated 2025-12-23

No results posted yet for this study

Summary

The aim of the study is to establish if caffeine consumption is associated with the evolution of the disease in premanifest HD.

Conditions

  • Huntington Disease

Sponsors & Collaborators

  • University Hospital, Lille

    lead OTHER

Principal Investigators

  • Clémence Simonin, MD · University Hospital, Lille

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-10-11
Primary Completion
2024-04-12
Completion
2024-04-12

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03034122 on ClinicalTrials.gov